Geron to Announce Second Quarter 2023 Financial Results on August 3, 2023
27 Julho 2023 - 5:30PM
Business Wire
Geron Corporation (Nasdaq: GERN), a late-stage clinical
biopharmaceutical company, today announced that it will release its
second quarter 2023 financial results on Thursday, August 3, 2023
at 4:00 p.m. Eastern Time via press release, which will be
available on the Company’s website at www.geron.com/investors.
Geron will host a conference call to discuss the financial results,
as well as business highlights, at 4:30 p.m. Eastern Time the same
day.
A live webcast of the conference call and related presentation
will be available on the Company’s website at
www.geron.com/investors/events. An archive of the webcast will be
available on the Company’s website for 30 days.
Participants may access the webcast by registering online using
the following link,
https://conferencingportals.com/event/SmvlMvWL.
About Geron
Geron is a late-stage clinical biopharmaceutical company
pursuing therapies with the potential to extend and enrich the
lives of patients living with hematologic malignancies. Its
investigational first-in-class telomerase inhibitor, imetelstat,
harnesses Nobel Prize winning science in a treatment that may alter
the underlying course of these diseases. To learn more, visit
http://www.geron.com/or follow us on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230727681262/en/
Aron Feingold Investor and Media Relations investor@geron.com
media@geron.com
Geron (NASDAQ:GERN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Geron (NASDAQ:GERN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024